Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911155 · ClinicalTrials.gov registry record
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 229
- Enrollment target
NCT02911155: Completed study, sponsored by National Cancer Institute (NCI).
NCT02911155 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02911155 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
Study Summary
Background: The field of nuclear medicine has changed a lot in the past decades. Technology has gotten better, so patients are exposed to less radiation. But now workers are doing procedures more often and using lead aprons less. So they may be exposed to more radiation. This may put them at higher risk for cancers and other health problems that are related to radiation. Researchers want to collect data from technologists to learn more about the risks and appropriate doses of radiation. Objective: To learn more about the risks and appropriate doses of radiation for nuclear medicine technologists. Eligibility: Adults who were first certified in nuclear medicine technology in the United States after 1980. They must be living in the United States. They must not be participants in the USRT study. Design: Participants will be recruited online. Participants will complete an online survey. It will take about a half hour. This will have questions about their work with nuclear medicine procedures. There will be questions about the kinds of procedures and how often they do them. Participants will give a short work history. This will include the names of current and past employers. Participants will allow researchers to get records of their film badge dose readings. These will come from dosimetry providers. Dosimetry data will not be shared with participants. Researchers can t ensure the how accurate or complete the data are.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2016-09-21 |
| Est. Completion | 2020-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911155
The ClinicalTrials.gov registry entry for NCT02911155 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02911155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02911155 about?
NCT02911155 is a clinical study titled "Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists". Background: The field of nuclear medicine has changed a lot in the past decades. Technology has gotten better, so patients are exposed to less radiation. But now workers are doing procedures more often and using lead aprons less. So they may be exposed to more radiation. This may put them at higher...
What is the current status of trial NCT02911155?
This trial is currently completed. The enrollment target is 229 participants. The study started on 2016-09-21. Estimated completion is 2020-05-01.
Who is sponsoring clinical trial NCT02911155?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.